AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 157 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,000 | -50.0% | 29 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | +100.0% | 29 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 29 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | 0.0% | 29 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | -50.0% | 29 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | – | 29 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q3 2019 | $1,000 | -75.0% | 18 | -65.4% | 0.00% | – |
Q2 2018 | $4,000 | -55.6% | 52 | -76.9% | 0.00% | -100.0% |
Q2 2016 | $9,000 | -40.0% | 225 | -2.2% | 0.00% | 0.0% |
Q4 2015 | $15,000 | – | 230 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |